Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
600332Pharmaceuticals
CN¥19.36−0.87%As of Oct 29vs prior close
- Market cap
- $4.1B
- P/E (TTM)
- 12.4×
- P/E (FY1)
- 12.2×
- From 52W high
- −29.27%
- EPS (LTM)
- CN¥1.58
- Revenue (LTM)
- CN¥77.9B
- Net margin
- 2.77%
Nomior Score
29
Steady ProfileBottom 14% of the scored universe
Growth27
Quality41
Value61
Momentum2
Resilience60
Growth
+3.13%revenue a year over 3 fiscal years
YE22 CN¥70.8BLTM CN¥77.9B
Connections
Revenue to profitYE25
4% of revenue became net profit.